Specific Comments on the IPO’s Draft Pharmaceutical Guidelines (2026)

/ By / Drug Regulation, Others, Patent

There is no easier way to put it – the IPO’s Draft Guidelines for Examination of Patent Applications in the Field of Pharmaceuticals, 2026 (“2026 Draft Guidelines”) released 15 days ago have severe problems and require substantial reworking. There are many concerning reasons warranting an immediate and thorough revision of this draft for it to avoid disrupting patent law and patent prosecution as we know it. The 2026 Draft Guidelines have misquoted certain statutory provisions, misinterpreted some judicial decisions, misapplied

Specific Comments on the IPO’s Draft Pharmaceutical Guidelines (2026) Read More »

Image with SpicyIP logo and the words "Weekly Review"

SpicyIP Weekly Review (September 7- September 13)

/ By / Copyright, Patent, Trademark

After another busy week and a long weekend, here we are with the SpicyIP Weekly Review with discussions on the Delhi High Court’s evolving approach to personality rights, a closer look at the Court’s decision in the Sugammadex patent dispute. We also had posts on copyright strikes and intermediary due diligence, the ongoing Ribociclib litigation before the Kerala High Court, the paper trail in IPRS v. Hotel Appolo, and the Delhi High Court’s evolving approach towards well-known marks and TM

SpicyIP Weekly Review (September 7- September 13) Read More »

SpicyIP Bells & Whistles: IP Events and Opportunities (15.09.2026)

/ By / Courses & Workshops, Opportunities

Welcome back to another week of Bells & Whistles. As always, we’ve rounded up a mix of developments, opportunities, and thoughtful reads from across the IP world along with a Bell of the Week that’s well worth revisiting. Bell of the Week: The Man Who Helped Build India’s Trademark Law Before every brand had a registration number, a trademark database, or a legal team ready to protect it, India had to first build a system for recognising and protecting trademarks. 

SpicyIP Bells & Whistles: IP Events and Opportunities (15.09.2026) Read More »

[Sponsored] IP8 Expands into Patent Decision Intelligence with Five Connected AI Workflows

/ By / Sponsored

A year after launching agentic AI for patent-infringement surveillance, IP8 expands across critical patent decision workflows for law firms and enterprise IP teams. To know more, read their press release below:- [Sponsored] IP8 Expands into Patent Decision Intelligence with Five Connected AI Workflows (13 September 2026) Pune, India— IP8 today announced the launch of its next-generation Patent Decision Intelligence Platform, expanding from its original focus on continuous patent-infringement surveillance and monetization into a unified platform spanning Novelty, Invalidity, Freedom-to-Operate (FTO),

[Sponsored] IP8 Expands into Patent Decision Intelligence with Five Connected AI Workflows Read More »

Section 14 is Not Section 25: Delhi High Court Revives Sugammadex Patent Bid

/ By / Patent

The Delhi High Court’s order in Fresenius Kabi v. Controller may ultimately turn on a Section 14 violation, but the concerns it flags go well beyond procedure, extending to hindsight, prior-art mosaicking, and the treatment of technical evidence. Pranay Borupothu examines the decision and unpacks these procedural and substantive concerns in the Controller’s reasoning. Pranay is a 3rd-year LL.B.(Hons.) student at Rajiv Gandhi School of Intellectual Property Law, IIT Kharagpur, and has a keen interest in IP laws. Section 14 is

Section 14 is Not Section 25: Delhi High Court Revives Sugammadex Patent Bid Read More »

SpicyIP Tidbit: IP LEX – A Welcome Cushion for Practitioners and Researchers!

/ By / Others, Publication

A solid step forward in accessing Indian IP Jurisprudence! DPIIT has come up with IP LEX, a digital repository of IP decision summaries created by the Office of the CGPDTM. It is natural for IP practitioners and researchers to find it difficult to keep track of legal developments. These developments emerge from judicial judgments, quasi-judicial decisions, and administrative orders – all scattered across various High Courts, quasi-judicial offices, commercial court websites, and e-Courts portals. Considering this, I am sure they

SpicyIP Tidbit: IP LEX – A Welcome Cushion for Practitioners and Researchers! Read More »

Unpacking Copyright Strikes, Safe Harbour and Due Diligence under the IT Rules : Part 2

/ By / Copyright

In continuation of Part 1, this Part tests the arguments run by the Platforms where they state that – striking content upon complaint and terminating accounts with repeated complaints is due diligence which the IT Act and Rules requires. The Concept of a “Voluntary” Takedown The third proviso to Rule 3(1)(d), in force from 2021 until 15 November 2025, had three notable features. It covered removal “under clause (b) on a voluntary basis” and removal on grievances under sub-rule (2).

Unpacking Copyright Strikes, Safe Harbour and Due Diligence under the IT Rules : Part 2 Read More »

Unpacking Copyright Strikes, Safe Harbour and Due Diligence under the IT Rules : Part 1

/ By / Copyright

The Delhi High Court has been recently grappling with issues concerning Copyright Strikes and takedowns by platforms, which have been necessitating Section 60 suits before the IPD Bench in Delhi.  In Saurabh Maurya v. John Doe, CS(COMM) 870 of 2026, the Instagram account of a content creator had been suspended upon copyright strikes. Inspite of restoration of the content by Meta, the Plaintiff has pressed that the mode and manner of dealing with copyright strikes by intermediary platforms is in

Unpacking Copyright Strikes, Safe Harbour and Due Diligence under the IT Rules : Part 1 Read More »

General Comment on the IPO’s Draft Pharmaceutical Guidelines (2026)

/ By / Drug Regulation, Others, Patent

A few days ago, we had informed our readers that they could participate in the open call for comments and suggestions on the Draft Guidelines for Examination of Patent Applications in the Field of Pharmaceuticals (2026). Several such notifications have been released by the office of the Controller General of Patents, Designs and Trademarks (CGPDTM) in the past few weeks (see here and here). The notification of the new draft of the Pharmaceutical Guidelines was released on September 4, 2026

General Comment on the IPO’s Draft Pharmaceutical Guidelines (2026) Read More »

[Part III] The Road Not Taken (Down): Delhi HC Starts Sorting the Personality Rights “Salad Platter”

/ By / Others

Continuing the discussion on an almost unending spate of personality rights filings (first part and second part), in the third part of the post, Aakanksha turns to fandom, fan merchandise, and fan participation in celebrification – and to some hopes for free speech uses of celebrity personality. Dr. Aakanksha Kumar (She/Her) is an independent researcher and academic. Since 2019, she has designed and taught a self-created elective course across law schools titled Comparative Celebrity Laws: Personality, Publicity and Free Speech

[Part III] The Road Not Taken (Down): Delhi HC Starts Sorting the Personality Rights “Salad Platter” Read More »

Scroll to Top